|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
US4588585A
(en)
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5567610A
(en)
|
1986-09-04 |
1996-10-22 |
Bioinvent International Ab |
Method of producing human monoclonal antibodies and kit therefor
|
|
US5892019A
(en)
|
1987-07-15 |
1999-04-06 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Production of a single-gene-encoded immunoglobulin
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5229275A
(en)
|
1990-04-26 |
1993-07-20 |
Akzo N.V. |
In-vitro method for producing antigen-specific human monoclonal antibodies
|
|
US5270163A
(en)
|
1990-06-11 |
1993-12-14 |
University Research Corporation |
Methods for identifying nucleic acid ligands
|
|
US6344321B1
(en)
|
1990-06-11 |
2002-02-05 |
Gilead Sciences, Inc. |
Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met
|
|
US5496938A
(en)
|
1990-06-11 |
1996-03-05 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands to HIV-RT and HIV-1 rev
|
|
US5705337A
(en)
|
1990-06-11 |
1998-01-06 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-SELEX
|
|
US5683867A
(en)
|
1990-06-11 |
1997-11-04 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: blended SELEX
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
ES2108048T3
(es)
|
1990-08-29 |
1997-12-16 |
Genpharm Int |
Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
|
|
DE69129154T2
(de)
|
1990-12-03 |
1998-08-20 |
Genentech, Inc., South San Francisco, Calif. |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
|
US5840867A
(en)
|
1991-02-21 |
1998-11-24 |
Gilead Sciences, Inc. |
Aptamer analogs specific for biomolecules
|
|
ES2134212T3
(es)
|
1991-04-25 |
1999-10-01 |
Chugai Pharmaceutical Co Ltd |
Anticuerpo humano reconstituido contra el receptor de la interleuquina 6 humano.
|
|
IE20030749A1
(en)
*
|
1991-05-03 |
2003-11-12 |
Indiana University Foundation |
Human notch and delta binding domains in torporythmic proteins, and methods based thereon
|
|
IL101728A
(en)
|
1991-05-03 |
2007-08-19 |
Univ Yale |
Human Abandonment and Delta, Restrictive Areas of Effect in Tophoric Proteins, and Methods Based on Them
|
|
US5582981A
(en)
|
1991-08-14 |
1996-12-10 |
Gilead Sciences, Inc. |
Method for identifying an oligonucleotide aptamer specific for a target
|
|
ATE463573T1
(de)
|
1991-12-02 |
2010-04-15 |
Medimmune Ltd |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
|
US20050112121A1
(en)
|
1992-04-30 |
2005-05-26 |
Yale University |
Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
|
|
US5786158A
(en)
*
|
1992-04-30 |
1998-07-28 |
Yale University |
Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
|
|
US5756291A
(en)
|
1992-08-21 |
1998-05-26 |
Gilead Sciences, Inc. |
Aptamers specific for biomolecules and methods of making
|
|
DE4425115A1
(de)
|
1994-07-15 |
1996-01-18 |
Boehringer Mannheim Gmbh |
Verfahren zur Modifizierung der Stabilität von Antikörpern
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
AU5752696A
(en)
|
1995-05-18 |
1996-11-29 |
Regents Of The University Of Michigan, The |
Dna binding antibodies
|
|
US6828422B1
(en)
|
1995-08-18 |
2004-12-07 |
Morphosys Ag |
Protein/(poly)peptide libraries
|
|
WO1997008320A1
(en)
|
1995-08-18 |
1997-03-06 |
Morphosys Gesellschaft Für Proteinoptimierung Mbh |
Protein/(poly)peptide libraries
|
|
DE19544393A1
(de)
|
1995-11-15 |
1997-05-22 |
Hoechst Schering Agrevo Gmbh |
Synergistische herbizide Mischungen
|
|
AU2160297A
(en)
|
1996-03-30 |
1997-10-22 |
Boehringer Mannheim Gmbh |
Method for the production of activated marked tumor-specific t cells and use thereof in treatment of tumors
|
|
JP2000512134A
(ja)
|
1996-05-31 |
2000-09-19 |
ザ ナショナル アメリカン レッド クロス |
Ｊａｇｇｅｄ／Ｎｏｔｃｈタンパク質および核酸に基づく治療および診断の方法および組成物
|
|
FR2751986B1
(fr)
|
1996-08-01 |
1998-12-31 |
Inst Nat Sante Rech Med |
Gene implique dans le cadasil, methode de diagnostic et application therapeutique
|
|
WO1998020142A1
(en)
|
1996-11-07 |
1998-05-14 |
Lorantis Limited |
Notch
|
|
DK0979281T3
(da)
|
1997-05-02 |
2005-11-21 |
Genentech Inc |
Fremgangsmåde til fremstilling af multispecifikke antistoffer med heteromultimere og fælles bestanddele
|
|
US6379925B1
(en)
|
1997-06-18 |
2002-04-30 |
The Trustees Of Columbia University In The City Of New York |
Angiogenic modulation by notch signal transduction
|
|
AU8162898A
(en)
|
1997-06-18 |
1999-01-04 |
Trustees Of Columbia University In The City Of New York, The |
Angiogenic modulation by notch signal transduction
|
|
US6692919B1
(en)
|
1997-07-23 |
2004-02-17 |
Yale University |
Activated forms of notch and methods based thereon
|
|
US7361336B1
(en)
|
1997-09-18 |
2008-04-22 |
Ivan Bergstein |
Methods of cancer therapy targeted against a cancer stem line
|
|
US6004528A
(en)
|
1997-09-18 |
1999-12-21 |
Bergstein; Ivan |
Methods of cancer diagnosis and therapy targeted against the cancer stemline
|
|
AU768269B2
(en)
|
1998-10-02 |
2003-12-04 |
Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The |
Apoptosis inducing agents and methods
|
|
US20030054360A1
(en)
|
1999-01-19 |
2003-03-20 |
Larry Gold |
Method and apparatus for the automated generation of nucleic acid ligands
|
|
US20030003572A1
(en)
|
1999-03-05 |
2003-01-02 |
David J. Anderson |
Isolation and enrichment of neural stem cells from uncultured tissue based on cell-surface marker expression
|
|
US20020010320A1
(en)
|
1999-04-05 |
2002-01-24 |
James W. Fett |
Chemeric and humanized antibodies to angiogenin
|
|
WO2001002588A2
(en)
|
1999-07-02 |
2001-01-11 |
Morphosys Ag |
Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests
|
|
US7605238B2
(en)
*
|
1999-08-24 |
2009-10-20 |
Medarex, Inc. |
Human CTLA-4 antibodies and their uses
|
|
US20030031670A1
(en)
|
1999-11-08 |
2003-02-13 |
Jack R. Wands |
Diagnosis and treatment of malignant neoplasms
|
|
DE10031380A1
(de)
|
2000-06-28 |
2002-01-10 |
Merck Patent Gmbh |
Verfahren zur Übertragung von Alkyliden-Gruppen auf organischen Verbindungen
|
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
US20080194022A1
(en)
|
2000-08-03 |
2008-08-14 |
Clarke Michael F |
Isolation and use of solid tumor stem cells
|
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
US20050089518A1
(en)
|
2001-12-07 |
2005-04-28 |
Clarke Michael F. |
Prospective identification and characterization of breast cancer stem cells
|
|
AU2001288628A1
(en)
|
2000-08-31 |
2002-03-13 |
Loyola University Chicago |
Method and reagents for treatment of skin disorders by modulating the notch pathway
|
|
US6689744B2
(en)
|
2000-09-22 |
2004-02-10 |
Genentech, Inc. |
Notch receptor agonists and uses
|
|
CA2425208C
(en)
|
2000-09-26 |
2013-04-09 |
Duke University |
Rna aptamers and methods for identifying the same
|
|
EP1322761A4
(en)
|
2000-10-02 |
2005-03-23 |
Korea Res Inst Of Bioscience |
HUMANIZED ANTIBODY AGAINST THE HEPATITE B VIRUS SURFACE ANTIGEN AND METHOD OF PREPARING THE SAME
|
|
DE60237969D1
(de)
|
2001-04-24 |
2010-11-25 |
Bayer Corp |
Menschliche antikörper gegen timp-1
|
|
US7356224B2
(en)
|
2001-07-03 |
2008-04-08 |
Brown University Research Foundation |
Method and apparatus for detecting multiple optical wave lengths
|
|
AU2002339157A1
(en)
|
2001-11-14 |
2003-05-26 |
Lorantis Limited |
Inhibitors of the notch signalling pathway for use in the treatment of cancer
|
|
GB0201674D0
(en)
|
2002-01-25 |
2002-03-13 |
Lorantis Ltd |
Medical treatment
|
|
EP1481090A4
(en)
|
2002-02-15 |
2006-08-09 |
Somalogic Inc |
METHOD AND REAGENTS FOR DETECTING BINDING OF TARGET MOLECULES BY NUCLEIC ACID ELECTRODES
|
|
AU2003278161A1
(en)
|
2002-06-21 |
2004-01-06 |
Johns Hopkins University School Of Medicine |
Membrane associated tumor endothelium markers
|
|
DE10228103A1
(de)
|
2002-06-24 |
2004-01-15 |
Bayer Cropscience Ag |
Fungizide Wirkstoffkombinationen
|
|
US20060263774A1
(en)
|
2002-11-01 |
2006-11-23 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
US20050124565A1
(en)
|
2002-11-21 |
2005-06-09 |
Diener John L. |
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
|
AU2003295089A1
(en)
|
2002-12-06 |
2004-06-30 |
Singapore General Hospital Pte Ltd |
Nogo, Caspr, F3 NB-3 useful in the treatment of injury and disease to the central nervous system
|
|
EP1608255A4
(en)
|
2003-04-01 |
2008-06-25 |
Univ Johns Hopkins Med |
ENDOTHELIAL CELL EXPRESSION PATTERN IN CHEST
|
|
US7425328B2
(en)
|
2003-04-22 |
2008-09-16 |
Purdue Pharma L.P. |
Tissue factor antibodies and uses thereof
|
|
US7563748B2
(en)
|
2003-06-23 |
2009-07-21 |
Cognis Ip Management Gmbh |
Alcohol alkoxylate carriers for pesticide active ingredients
|
|
WO2005024042A2
(en)
|
2003-09-04 |
2005-03-17 |
The Regents Of The University Of California |
Aptamers and methods for their in vitro selection and uses thereof
|
|
GB0321805D0
(en)
|
2003-09-18 |
2003-10-15 |
Univ Wales Medicine |
Human tumour growth patterns
|
|
AU2004294563B2
(en)
|
2003-11-26 |
2009-03-26 |
Health Research, Inc. |
Use of notch pathway interfering agents for treatment of plasma cell disorders
|
|
WO2005074633A2
(en)
|
2004-02-03 |
2005-08-18 |
The Regents Of The University Of Michigan |
Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
|
|
FR2867784B1
(fr)
|
2004-03-17 |
2006-06-09 |
Commissariat Energie Atomique |
Aptameres selectionnes a partir de cellules vivantes tumorales et leurs applications
|
|
EP1730531B1
(en)
*
|
2004-03-24 |
2014-01-15 |
Technion Research and Development Foundation, Limited |
Electrode
|
|
US20050239134A1
(en)
|
2004-04-21 |
2005-10-27 |
Board Of Regents, The University Of Texas System |
Combinatorial selection of phosphorothioate single-stranded DNA aptamers for TGF-beta-1 protein
|
|
WO2005111072A2
(en)
|
2004-04-29 |
2005-11-24 |
The Trustees Of Columbia University In The City Of New York |
Notch-based fusion proteins and uses thereof
|
|
RU2346996C2
(ru)
|
2004-06-29 |
2009-02-20 |
ЮРОПИЭН НИКЕЛЬ ПиЭлСи |
Усовершенствованное выщелачивание основных металлов
|
|
US20070077245A1
(en)
|
2004-08-04 |
2007-04-05 |
The Brigham And Women's Hospital, Inc. |
NOTCH mutations leading to increased receptor signaling
|
|
GB0421838D0
(en)
|
2004-09-30 |
2004-11-03 |
Congenia S R L |
Cancer markers
|
|
WO2006053063A2
(en)
|
2004-11-05 |
2006-05-18 |
The Regents Of The University Of California |
Notch-1 assay to detect neurodegenerative diseases
|
|
RU2392961C2
(ru)
|
2004-11-10 |
2010-06-27 |
Хубрехт Лабораториум |
Лечение аденомы и/или аденокарциномы кишечника с помощью ингибирования активации пути notch
|
|
CA2629330C
(en)
|
2004-11-12 |
2018-05-22 |
Cambridge University Technical Services Ltd. |
Methods and means related to cancer stem cells
|
|
WO2006110585A2
(en)
|
2005-04-07 |
2006-10-19 |
Novartis Vaccines And Diagnostics Inc. |
Cancer-related genes (prlr)
|
|
KR101280096B1
(ko)
|
2005-06-29 |
2013-06-28 |
컴퓨메딕스 리미티드 |
전도성 브리지를 포함하는 센서 어셈블리
|
|
US7723112B2
(en)
|
2005-10-31 |
2010-05-25 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
US20090305310A1
(en)
|
2005-11-22 |
2009-12-10 |
University Of Vermont And State Agricultural College |
Methods for Determining Notch Signaling and Uses Thereof
|
|
JP5489465B2
(ja)
|
2005-12-16 |
2014-05-14 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
Ｄｌｌ４アンタゴニストによって腫瘍増殖を阻害する治療方法
|
|
WO2007075915A2
(en)
|
2005-12-22 |
2007-07-05 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Monoclonal antibodies against orthopoxviruses
|
|
AR059922A1
(es)
|
2006-04-01 |
2008-05-07 |
Galaxy Biotech Llc |
Anticuerpos monoclonales humanizados para el factor de crecimiento de hepatocitos
|
|
US20080241150A1
(en)
|
2006-05-15 |
2008-10-02 |
The Brigham And Women's Hospital, Inc. |
Functional negative regulatory domain sequences from human NOTCH1 and 2 and isolated LNR domains from human NOTCH1
|
|
KR20090016762A
(ko)
|
2006-06-06 |
2009-02-17 |
제넨테크, 인크. |
혈관 발달을 조정하기 위한 조성물 및 방법
|
|
CA2654000A1
(en)
|
2006-06-06 |
2008-05-22 |
Genentech, Inc. |
Anti-dll4 antibodies and methods using same
|
|
PL2032166T3
(pl)
|
2006-06-13 |
2013-09-30 |
Oncomed Pharm Inc |
Kompozycje i sposoby diagnozowania i leczenia nowotworów
|
|
TW200801513A
(en)
|
2006-06-29 |
2008-01-01 |
Fermiscan Australia Pty Ltd |
Improved process
|
|
CA2664738C
(en)
|
2006-09-29 |
2017-03-07 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
|
WO2008050525A1
(en)
|
2006-09-29 |
2008-05-02 |
Konica Minolta Opto, Inc. |
Retardation film
|
|
CL2007002989A1
(es)
|
2006-10-19 |
2008-05-16 |
Genentech Inc |
Anticuerpos anti-notch3; acido nucleico que los codifica; vector y celula que lo comprende; metodo de produccion; y su uso para el diagnostico de enfermedades relacionadas con notch3.
|
|
CL2007002987A1
(es)
|
2006-10-19 |
2008-06-06 |
Genentech Inc |
Anticuerpos anti-notch3; acido nucleico que los codifica; vector y celula que lo comprende; metodo de produccion; y su uso para tratar enfermedades relacionadas con notch3.
|
|
WO2008048680A2
(en)
|
2006-10-19 |
2008-04-24 |
Maine Medical Center Research Institute |
Notch 2 signaling as a breast cancer suppressor pathway
|
|
US20100068688A1
(en)
|
2006-11-06 |
2010-03-18 |
Howard Shapiro |
Management of teaching processes for individualized instruction in a multistudent environment
|
|
NO347649B1
(no)
|
2006-12-14 |
2024-02-12 |
Regeneron Pharma |
Humant antistoff eller antistoff fragment som spesifikt binder human deltaliknende ligand 4 (hDII4), nukleinsyremolekyl som koder for slike og vektor og vert-vektorsystemer, samt fremgangsmåte for fremstilling, sammensetning og anvendelse.
|
|
NZ577274A
(en)
|
2006-12-18 |
2012-10-26 |
Genentech Inc |
Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases
|
|
WO2008079326A2
(en)
|
2006-12-20 |
2008-07-03 |
Vasgene Therapeutics, Inc. |
Methods for using and identifying modulators of delta-like 4
|
|
US8088617B2
(en)
|
2007-01-24 |
2012-01-03 |
Oncomed Pharmaceuticals, Inc. |
Antibodies that bind the glutamate ligand binding region of Notch1
|
|
US20100119526A1
(en)
|
2007-01-26 |
2010-05-13 |
Bioinvent International Ab |
DLL4 Signaling Inhibitors and Uses Thereof
|
|
WO2008100563A2
(en)
|
2007-02-14 |
2008-08-21 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
|
WO2008109075A2
(en)
*
|
2007-03-05 |
2008-09-12 |
Bristol-Myers Squibb Company |
Biomarkers and methods for determining sensitivity to ctla-4 antagonists
|
|
EP2134356A2
(en)
|
2007-03-05 |
2009-12-23 |
Board of Regents, The University of Texas System |
Negative genetic regulation of cancer cell renewal in synergy with notch- or numb-specific immunotherapy
|
|
PE20090321A1
(es)
*
|
2007-06-04 |
2009-04-20 |
Genentech Inc |
Anticuerpos anti-notch1 nrr, metodo de preparacion y composicion farmaceutica
|
|
NZ583367A
(en)
|
2007-07-16 |
2012-10-26 |
Genentech Inc |
Anti-cd79b antibodies and immunoconjugates and methods of use
|
|
KR20100076947A
(ko)
|
2007-08-23 |
2010-07-06 |
더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕 |
인간화 노치 융합 단백질 조성물 및 치료방법
|
|
US20110166028A1
(en)
|
2007-08-28 |
2011-07-07 |
Donald Bergstrom |
Methods for predicting treatment response based on the expression profiles of biomarker genes in notch mediated cancers
|
|
US8377886B2
(en)
|
2007-09-14 |
2013-02-19 |
Albert Einstein College Of Medicine Of Yeshiva University |
Use of gamma secretase inhibitors and notch pathway inhibitors for treatment and prevention of renal disease
|
|
WO2009036167A1
(en)
|
2007-09-14 |
2009-03-19 |
Vanderbilt University |
Targeting of notch3 receptor function for cancer therapy
|
|
US20120082659A1
(en)
|
2007-10-02 |
2012-04-05 |
Hartmut Land |
Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations
|
|
US8119366B2
(en)
|
2007-10-05 |
2012-02-21 |
Trojan Technologies, Ltd. |
Antennapedia-dominant negative mastermind-like construct
|
|
WO2009124931A2
(en)
|
2008-04-07 |
2009-10-15 |
Ablynx Nv |
Amino acid sequences directed against the notch pathways and uses thereof
|
|
WO2010000020A1
(en)
|
2008-06-30 |
2010-01-07 |
Cathrx Ltd |
A catheter
|
|
EP2307051B1
(en)
|
2008-07-08 |
2015-02-11 |
OncoMed Pharmaceuticals, Inc. |
Notch-binding agents and antagonists and methods of use thereof
|
|
US9132189B2
(en)
|
2008-07-08 |
2015-09-15 |
Oncomed Pharmaceuticals, Inc. |
Notch1 binding agents and methods of use thereof
|
|
AU2009298569A1
(en)
|
2008-10-01 |
2010-04-08 |
Genentech, Inc. |
Anti-Notch2 antibodies and methods of use
|
|
US8425930B2
(en)
|
2009-03-13 |
2013-04-23 |
The Regents Of The University Of California |
Prebiotic oligosaccharides
|
|
CA2775880A1
(en)
|
2009-09-30 |
2011-04-07 |
Genentech, Inc. |
Anti-notch3 antagonist antibodies to treat gamma secretase inhibitor responsive and anti-notch1 antagonist antibody unresponsive t-cell leukemias
|
|
DE102009047243A1
(de)
|
2009-11-27 |
2011-06-01 |
Orgentec Diagnostika Gmbh |
Monospezifische Polypeptidreagenzien
|
|
WO2011088215A2
(en)
|
2010-01-13 |
2011-07-21 |
Oncomed Pharmaceuticals, Inc. |
Notch1 binding agents and methods of use thereof
|
|
NZ601743A
(en)
|
2010-02-12 |
2014-11-28 |
Oncomed Pharm Inc |
Methods for identifying and isolating cells expressing a polypeptide
|
|
JP5450221B2
(ja)
|
2010-04-14 |
2014-03-26 |
株式会社神戸製鋼所 |
高電流密度ガスシールドアーク溶接方法
|
|
MX355418B
(es)
|
2010-05-04 |
2018-04-18 |
Five Prime Therapeutics Inc |
Anticuerpos que se unen a factor estimulante de colonias 1 (csf1r).
|
|
WO2012003472A1
(en)
|
2010-07-02 |
2012-01-05 |
Aveo Pharmaceuticals, Inc. |
Anti-notch1 antibodies
|
|
EP3556774B1
(en)
|
2011-03-11 |
2024-01-03 |
Beth Israel Deaconess Medical Center Inc. |
Anti-cd40 antibodies and uses thereof
|
|
CA2864197A1
(en)
|
2011-11-16 |
2013-05-23 |
Oncomed Pharmaceuticals, Inc. |
Human notch receptor mutations and their use
|
|
WO2013173542A1
(en)
|
2012-05-16 |
2013-11-21 |
Oncomed Pharmaceuticals, Inc. |
Methods for treating cancer with notch2/3 antibodies
|
|
CA2883703C
(en)
|
2012-09-04 |
2021-10-19 |
Eleison Pharmaceuticals, Llc |
Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
|
|
CA2885659A1
(en)
|
2012-09-21 |
2014-03-27 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating hematological malignancies with notch1 antibodies
|
|
KR20150082548A
(ko)
|
2012-11-07 |
2015-07-15 |
화이자 인코포레이티드 |
항-notch3 항체 및 항체-약물 접합체
|
|
CA2900969A1
(en)
|
2013-03-15 |
2014-09-25 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating pancreatic cancer
|
|
CA2941733A1
(en)
|
2014-03-07 |
2015-09-11 |
Oncomed Pharmaceuticals, Inc. |
Methods for treating cancer with notch1 antibodies
|
|
WO2015153997A2
(en)
|
2014-04-04 |
2015-10-08 |
Oncomed Pharmaceuticals, Inc. |
Notch3 antibodies and uses thereof
|